Humanized Mouse Models for Transplant Immunology

Our understanding of the molecular pathways that control immune responses, particularly immunomodulatory molecules that control the extent and duration of an immune response, have led to new approaches in the field of transplantation immunology to induce allograft survival. These molecular pathways...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of transplantation Vol. 16; no. 2; pp. 389 - 397
Main Authors Kenney, L.L., Shultz, L.D., Greiner, D.L., Brehm, M.A.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2016
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Our understanding of the molecular pathways that control immune responses, particularly immunomodulatory molecules that control the extent and duration of an immune response, have led to new approaches in the field of transplantation immunology to induce allograft survival. These molecular pathways are being defined precisely in murine models and translated into clinical practice; however, many of the newly available drugs are human-specific reagents. Furthermore, many species-specific differences exist between mouse and human immune systems. Recent advances in the development of humanized mice, namely, immunodeficient mice engrafted with functional human immune systems, have led to the availability of a small animal model for the study of human immune responses. Humanized mice represent an important preclinical model system for evaluation of new drugs and identification of the mechanisms underlying human allograft rejection without putting patients at risk. This review highlights recent advances in the development of humanized mice and their use as preclinical models for the study of human allograft responses.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1600-6135
1600-6143
DOI:10.1111/ajt.13520